Rheumatology
<ѻýҕl class='mpt-top_cat_title_description'>News, opinions and meeting coverage in rheumatology.ѻýҕl>
<ѻýҕl>Make the Diagnosis: Why Did This Toddler Stop Walking?ѻýҕl>
Case Study: A fourteen-month-old boy had abruptly stopped bearing weight on his left lower extremity. Parents reported no history of trauma to the limb, but the boy’s medical history included undescended testes. On presentation, the patient had a fever of 100.4°F, which rose to 101.5°F He held his left leg externally rotated and flexed at the hip and refused to extend or bear weight on the limb or crawl. The left hip was tender, but without any palpable masses. He showed minimal signs of discomfort with passive rotation and axial loading. The passive range of motion of the hip showed limitations in extension and adduction.
Aug 27, 2014
<ѻýҕl>Orencia Combo Tops in Early, Severe RAѻýҕl>
PARIS -- In a study of patients with poor-prognosis early rheumatoid arthritis, more patients treated with abatacept (Orencia) plus methotrexate were in remission at 1 year than were those on methotrexate alone, a researcher reported here.
Jun 12, 2014
<ѻýҕl>Vaccines and Biologics: Questions Remainѻýҕl>
Vaccinations for patients with autoimmune diseases -- specifically patients being treated with biologics -- bring with them a variety of issues, including disease-specific, medication-related, and vaccine-associated factors, researchers suggested.
May 24, 2014
<ѻýҕl>Medtronic's Infuse Moves From Operating Room to Courtroomѻýҕl>
An investigative series by ѻýҕl/Milwaukee Journal Sentinel has been tracking the spinal fusion device called Infuse in a 4-year-long series and now reports how a flawed FDA system for device approval may have led to a long string of adverse events culminating in thousands of liability suits.
May 18, 2014
<ѻýҕl>Rheuminations: Blame the Pain on the Rain?ѻýҕl>
Do your arthritis patients complain that their symptoms are influenced by the cold and wet weather? There's plenty of support for this, including a new study out of the Netherlands seeking to quantify this link and examine contributing factors.
Mar 16, 2014
<ѻýҕl>Rituxan Offers Little Help for Sjogren'sѻýҕl>
Treatment for primary Sjogren's syndrome with the B-cell depleting antibody rituximab (Rituxan) failed to provide statistically significant improvements, despite the increasing evidence for B cells in the pathogenesis of this disorder, French researchers reported.
Feb 18, 2014
<ѻýҕl>Killing Pain: Tramadol the 'Safe' Drug of Abuseѻýҕl>
Almost 2 decades have passed since the FDA approved tramadol as a 'safe' opioid, but the intervening years provide evidence to question that 'safe' claim, as this latest investigation by John Fauber for the Milwaukee Journal Sentinel-ѻýҕl revealed.
Dec 22, 2013